John Wiley & Sons (JW-A) Tops Q3 EPS by 2c

John Wiley & Sons (NYSE: JW-A) reported Q3 EPS of $0.99, $0.02 better than the analyst estimate of $0.97. Revenue for the quarter came in at $466 million versus the consensus estimate of $478 million.

For earnings history and earnings-related data on John Wiley & Sons (JW-A) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• Star Equity to acquire Harte Hanks for $5.00 per share